The researchers applied exogenous abscisic acid, commonly abbreviated ABA, to germinating wheat seeds at four concentrations: zero as a control, 2, 4, and 6 milligrams per liter. Their physiological measurements revealed a striking biphasic response. At the lowest dose, 2 milligrams per liter, primary root length actually increased by about 12 percent compared with untreated seeds. But at 4 milligrams per liter and above, growth was significantly inhibited, and at 6 milligrams per liter root length dropped by a dramatic 40 percent. This concentration-dependent switch between promotion and inhibition mirrors the classic biphasic behavior of ABA documented in other plant species, but the team wanted to understand what was happening inside the seed at the molecular level.

Physiological markers told a story of progressive oxidative stress. As ABA concentrations rose, the researchers measured increasing levels of electrolyte leakage, malondialdehyde, and catalase activity, all statistically significant at the higher doses. Electrolyte leakage signals damage to cell membranes, malondialdehyde is a well-established byproduct of membrane lipid peroxidation, and catalase is a key antioxidant enzyme that breaks down hydrogen peroxide. Together, these markers indicate that high ABA concentrations trigger a burst of reactive oxygen species that overwhelms the seed’s antioxidant defenses, leading to membrane damage and metabolic dysfunction. The team identified roughly 4 milligrams per liter as the threshold beyond which oxidative damage becomes pronounced.

To peer inside the molecular machinery, the researchers sequenced the transcriptomes of seeds treated with 6 milligrams per liter ABA and compared them with untreated controls. They identified 854 differentially expressed genes, with 470 up-regulated and 384 down-regulated. Gene Ontology enrichment showed that these genes were predominantly involved in cellular processes, metabolic processes, catalytic activity, and transporter activity, suggesting a broad remodeling of the seed’s biochemical and transport networks. KEGG pathway analysis highlighted the activation of linoleic acid metabolism, alpha-linolenic acid metabolism, glycolysis and gluconeogenesis, and the biosynthesis of amino acids, pathways that collectively point to ROS scavenging, energy provision, and protein homeostasis as central themes of the ABA response.

The metabolomic analysis was equally revealing. Untargeted liquid chromatography mass spectrometry detected more than 21,000 metabolic features, annotated as over 6,000 compounds, and identified 665 differentially accumulated metabolites between the control and high-ABA treatments, with 345 up-regulated and 320 down-regulated. Lipids constituted the largest altered category at 15.5 percent of the differentially accumulated metabolites, followed by ketones, aldehydes, and esters at 15.6 percent, with organic acids, saccharides, terpenoids, and amino acids also showing significant changes. KEGG enrichment singled out benzoxazinoid biosynthesis and nicotinate and nicotinamide metabolism as the pathways with the largest shifts, suggesting that the seed mobilizes defensive secondary metabolites and NAD-related metabolism in response to the hormone stress.

The real power of the study came from integrating the two data streams. Co-expression network analysis revealed strong positive correlations between differentially expressed genes and differentially accumulated metabolites, and joint KEGG enrichment identified 10 core pathways that orchestrate the ABA response, including glycolysis and gluconeogenesis, amino acid biosynthesis, cysteine and methionine metabolism, starch and sucrose metabolism, and ABC transporters. Crucially, the analysis pinpointed two types of hub nodes that appear repeatedly across multiple pathways. The metabolite L-serine was enriched in five separate pathways, acting as a carbon-nitrogen flux node that balances resource allocation. On the gene side, TraesCS3A02G276100, a glycolytic enzyme gene, co-regulated starch and sucrose metabolism, fructose and mannose metabolism, and glycolysis, coordinating carbon partitioning for energy homeostasis. Another gene, TraesCS5A02G398300, modulated amino acid biosynthesis and cysteine and methionine metabolism, the latter supplying glutathione precursors for ROS scavenging.

Based on these findings, the researchers propose a working model in which energy supply through glycolysis, the ROS scavenging system, and nitrogen metabolism through amino acid balance form a functionally interconnected network that responds to high ABA stress. Under severe ABA treatment, the data suggest attenuated glycolysis, decreased ATP levels, altered amino acid profiles, and accumulated ROS, collectively pointing to a state of overall metabolic dysfunction. The team emphasizes that this model is built on correlative data and that future functional validation through gain-of-function and loss-of-function experiments, along with metabolic flux analysis, will be needed to establish causality.

The study also revealed an intriguing connection between ABA and linolenic acid metabolism. The recurrent enrichment of the gene TraesCS5B02G078300 suggests that ABA promotes the synthesis of jasmonate precursors, signaling molecules involved in plant defense. Meanwhile, the activation of benzoxazinoid biosynthesis points to the mobilization of secondary metabolites that mitigate oxidative damage. The researchers propose an ABA-induced adaptation axis in which the hormone triggers lipid oxidation for signaling while simultaneously mobilizing protective secondary metabolites to counter the oxidative stress it provokes.

The implications extend beyond basic plant biology. ABA is already known to enhance carbohydrate accumulation and remobilization to grains in wheat under water stress, and foliar ABA application has been shown to increase yield in field conditions. By identifying the molecular hubs and core pathways that respond to exogenous ABA, this study lays a theoretical foundation for developing ABA-based seed treatment technologies and stress-resistant breeding strategies. The researchers suggest that future studies could refine the dose-response relationship by incorporating wider concentration gradients and calculating the half-maximal inhibitory concentration, providing a more quantitative framework for agricultural applications.

What makes this study particularly compelling is the elegance of the biphasic response it documents. A single hormone, applied at different concentrations, can either gently nudge a germinating seed toward enhanced growth or push it into a full-blown stress response with membrane damage and metabolic collapse. The identification of L-serine and specific multi-pathway genes as critical network nodes offers concrete molecular targets for future crop improvement efforts. As climate change intensifies abiotic stresses on global agriculture, understanding how the world’s most important cereal crop fine-tunes its gene expression and metabolic networks in response to a key stress hormone could prove invaluable for breeding the resilient wheat varieties of tomorrow.

Subject of Research: Integrated transcriptomic and metabolomic analysis of wheat germinating seed response to exogenous abscisic acid stress

Article Title: Integrated transcriptomic and metabolomic analysis reveals the molecular mechanisms underlying wheat germinating seed response to exogenous abscisic acid stress

Article References: Wang, X., Chen, C., Sun, X., & Wang, C. (2025). Integrated transcriptomic and metabolomic analysis reveals the molecular mechanisms underlying wheat germinating seed response to exogenous abscisic acid stress. Frontiers in Plant Physiology, 3, Article 1684534. https://doi.org/10.3389/fphgy.2025.1684534

Image Credits: AI Generated

DOI: 10.3389/fphgy.2025.1684534

Keywords: wheat, abscisic acid, seed germination, transcriptomics, metabolomics, oxidative stress, multi-omics, metabolic reprogramming, plant physiology, stress response, L-serine, crop breeding

For decades, L-serine was classified as a non-essential amino acid, meaning scientists assumed the brain could synthesize sufficient quantities internally through the phosphorylated pathway. Experiments in adult mice supported this view: deleting Phgdh, the gene encoding a key enzyme in the brain’s de novo serine synthesis, sharply reduces brain L-serine levels, indicating that local production dominates in mature animals. Yet the new work, led by Akshay K. Tiwari and Herman Wolosker of the Technion Israel Institute of Technology together with colleagues in Israel, the United States, and Switzerland, demonstrates that this picture is incomplete, particularly during early life. The developing brain, it seems, depends heavily on a supply line from the blood.

The researchers began by testing what happens when dietary serine disappears. Three-week-old mice were placed on a diet deficient in both serine and glycine, the latter restricted to prevent the two amino acids from replenishing one another through biochemical interconversion. After just ten days, high-performance liquid chromatography revealed that hippocampal L-serine had fallen by 45 percent and D-serine by 60 percent, with similar drops in the cerebral cortex. Serum serine and glycine also declined, confirming that the diet had genuinely restricted the amino acids reaching the brain. Because D-serine is manufactured inside the brain from L-serine by the enzyme serine racemase, the result made one thing clear: dietary L-serine is a major determinant of brain D-serine levels, and by extension, of the signaling molecules that calibrate NMDA receptor activity.

The metabolic consequences extended far beyond serine itself. Targeted metabolomics showed widespread reprogramming in the cortex, liver, and kidneys, with reductions in the serine precursor phosphoserine, pyruvate, and alpha-ketoglutarate, and increases in metabolites such as acetyl-CoA, NADPH, and sedoheptulose 7-phosphate. Perhaps most concerning was the fate of sphingolipids, the fatty molecules that build cellular membranes. When serine becomes scarce, the enzyme serine palmitoyltransferase substitutes alanine in its condensation reaction, producing 1-deoxysphinganine and, ultimately, a family of atypical lipids called 1-deoxysphingolipids. These compounds are cytotoxic and are known culprits in hereditary sensory and autonomic neuropathy type 1 and diabetic neuropathy. In the serine-deprived mice, the brain alanine-to-serine ratio doubled, and sphingolipidomic analysis revealed a striking accumulation of 1-deoxydihydroceramide species in the hippocampus. Gene expression shifted as well, with circadian rhythm genes such as Bmal1, Cry1, Per2, and Dbp downregulated, and several endothelium-enriched genes, including Cldn5 and Mfsd2a, altered alongside them.

Having established that blood-borne serine matters, the team set out to find which transporter ferries it across the blood-brain barrier. Two endothelial serine transporters, SLC38A5 and SLC1A4, were already known, but deleting them reduces brain L-serine by only 15 to 20 percent and 10 percent respectively, leaving a gap too large to explain the dietary effects. Mining RNA sequencing datasets and a human brain microvessel proteomics database, the researchers identified SLC38A2, also called SNAT2, as a strong candidate. This broad-spectrum neutral amino acid transporter of the system A family was known to move serine, alanine, glutamine, and other substrates in vitro, but its physiological role at the blood-brain barrier had never been defined. To settle the question, the team created mice in which Slc38a2 was selectively deleted from endothelial cells by crossing floxed animals with Tie2-Cre lines, then confirmed the deletion in purified brain microvessels by western blot.

The knockout animals told a remarkably selective story. Untargeted metabolomics of the cortex and hippocampus of eleven-day-old pups revealed that total serine was the only metabolite consistently reduced, with its precursor phosphoserine dropping in parallel; no other SLC38A2 substrate was measurably affected. HPLC analysis confirmed that both hippocampal L-serine and D-serine declined in the knockout pups, while serum amino acid levels remained normal, pointing to a brain-specific effect. When the researchers injected radiolabeled L-serine directly into the heart of the animals and measured its extraction into brain tissue ten seconds later, uptake in the knockout pups fell by 45 percent, while kidney uptake was unchanged. Fluorescein permeability assays confirmed that the barrier itself remained intact, ruling out nonspecific leakage.

Immunoelectron microscopy added a fascinating structural dimension. Gold particles labeling SLC38A2 decorated both the luminal membrane, facing the blood, and the abluminal membrane, facing the brain tissue, of endothelial cells in the neocortex, along with some intracellular signal. This dual placement means the transporter can, in principle, mediate flux in either direction depending on concentration gradients, and the isotope tracing experiments suggested exactly that. Whereas brain uptake of radiolabeled L-serine fell in the knockouts, the extraction of L-glutamine into the brain more than doubled, implying that glutamine transport through SLC38A2 normally runs in the opposite direction, from brain to blood. Stable isotope tracing with doubly labeled serine and uniformly labeled glucose confirmed that the brain’s internal serine synthesis from glucose was not compensating for the loss, and that glycine production was largely spared, with a cortical increase in glycine synthesis from glucose suggesting an adaptive mechanism to maintain glycine levels.

The developmental consequences were visible in the finest architectural details of the brain. Electron microscopic analysis of the dentate gyrus, a region undergoing intense synaptogenesis in the second week of life, revealed that asymmetric, predominantly glutamatergic synapses were selectively vulnerable in the knockout pups. The presynaptic vesicle clusters of these excitatory synapses were 25 percent smaller than in wild-type littermates, with the size distribution shifted toward smaller values, and the postsynaptic density area was similarly reduced. Symmetric, largely GABAergic synapses were unaffected, as was the total number of synapses of either type. Notably, markers of neurons and astrocytes, including NeuN, PSD-95, and GFAP, were unchanged, and bulk RNA sequencing detected only a handful of differentially expressed genes, indicating that the primary defect is metabolic rather than a broad developmental failure. Behavioral testing showed that negative geotaxis, grip strength, and limb suspension reflexes were all preserved, suggesting the pups are resilient to these subtle synaptic changes.

The story grew more nuanced as the mice matured. In juvenile and adult knockout animals, L-serine levels recovered, but D-serine remained persistently low, indicating that luminal SLC38A2 continues to import serine even when circulating concentrations fall after weaning. Meanwhile, glutamine and proline accumulated dramatically in the hippocampi of older knockout mice, implying that in adults, abluminal SLC38A2 normally exports these amino acids from the brain into the blood. Because glutamine and proline both serve as vehicles for ammonia disposal, the authors propose that SLC38A2 helps the aging brain rid itself of excess nitrogen, a function that becomes increasingly important as brain glutamine synthetase activity rises several-fold after the neonatal period. The finding echoes earlier work showing that other blood-brain barrier serine transporter deletions, including SLC38A5 and SLC1A4, also produce excitatory synaptic abnormalities, though the SLC38A2 phenotype proved milder, hinting that additional serine transporters partially compensate.

The therapeutic implications are already taking shape. On one side, blocking luminal SLC38A2 could dampen D-serine synthesis in conditions marked by NMDA receptor overactivation, such as epilepsy and traumatic brain injury, where excess astrocytic D-serine contributes to synaptic damage. On the other, the transporter may represent a metabolic weak point in brain cancer: glioblastoma growth depends on dietary L-serine crossing the blood-brain barrier, and SLC38A2 is overexpressed in these tumors, raising the prospect that selective inhibitors could starve the malignancy of an essential building block. Intriguingly, SLC38A2 expression is reduced in the dorsolateral prefrontal cortex of people with schizophrenia, a disorder closely tied to NMDA receptor hypofunction, opening a possible link between vascular amino acid transport and psychiatric disease. The authors caution that SLC38A2 is a contributor to brain serine import rather than necessarily the sole or dominant transporter, and that future work combining deletions of multiple endothelial serine transporters will be needed to complete the picture. Still, the study rewrites a fundamental rule of neurochemistry: the developing brain is not a self-sufficient serine factory, but an organ that relies on its vascular gatekeepers, and on the diet itself, to build the synapses that make thought possible.

Subject of Research: Role of the endothelial blood-brain barrier transporter SLC38A2 in brain L-serine and D-serine homeostasis and synapse development

Article Title: Endothelial SLC38A2 controls brain D-serine homeostasis and synapse development

Article References: Tiwari, A. K., Lahkar, A., Sajrawi, C., Hussein, Y., Majcher, A., Bonelli, S., Agranovich, B., Abramovich, I., Stern, S., Chaudhry, F. A., Hornemann, T., Radzishevsky, I., & Wolosker, H. (2026). Endothelial SLC38A2 controls brain D-serine homeostasis and synapse development. iScience, 29(10), Article 117487. https://doi.org/10.1016/j.isci.2026.117487

Image Credits: AI Generated

DOI: 10.1016/j.isci.2026.117487

Keywords: SLC38A2, blood-brain barrier, L-serine, D-serine, NMDA receptors, synapse development, amino acid transport, sphingolipids, metabolomics, glioblastoma, endothelial cells, brain development